Literature DB >> 7591149

Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites.

T Imamura1, J Potempa, R N Pike, J N Moore, M H Barton, J Travis.   

Abstract

Infection by Porphyromonas gingivalis is strongly associated with adult periodontitis, with proteinases from this bacterium now considered to be important virulence factors. In order to investigate possible pathological functions of these enzymes, we examined the effect of both free and vesicle-bound forms of the two major cysteine proteinases (gingipains) of P. gingivalis on plasma clot formation by using thrombin time (TT) measurements. Both Lys-gingipain (gingipain-K) and Arg-gingipain (gingipain-R) prolonged plasma TT in a dose- and time-dependent manner, and this was also found with vesicles which are the biological carriers of P. gingivalis proteinases. The increase in plasma TT by vesicles could be completely reversed by treatment with nonspecific cysteine proteinase inhibitors but only partially by compounds selective for either gingipain-K or gingipain-R. Preincubation of vesicles with a gingipain-K-specific inhibitor (z-FK-ck) reduced plasma TT more than a gingipain-R-specific inhibitor (leupeptin), suggesting that under physiological conditions gingipain-K was more effective in fibrinogen destruction. Each purified enzyme also markedly increased fibrinogen TT, gingipain-R being fourfold more potent than gingipain-K. However, in plasma, gingipain-R was ineffective because of the inhibitory effect of albumin. These results imply that cysteine proteinases, especially gingipain-K, abrogate the clotting potential of fibrinogen and, therefore, may contribute to the bleeding tendency and to persistent inflammation in periodontitis sites infected with P. gingivalis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591149      PMCID: PMC173698          DOI: 10.1128/iai.63.12.4877-4882.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Fibrinolytic activity of oral anaerobic bacteria.

Authors:  D Nitzan; J F Sperry; T D Wilkins
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

2.  Interactions of Bacteroides gingivalis with fibrinogen.

Authors:  M S Lantz; R W Rowland; L M Switalski; M Höök
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

3.  The chemotactic activity of fibrin lysis products.

Authors:  V J Stecher; E Sorkin
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

Review 4.  Human plasminogen.

Authors:  F J Castellino; J R Powell
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 5.  Fibrinogen and fibrin.

Authors:  R F Doolittle
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

6.  Degradation of albumin, haemopexin, haptoglobin and transferrin, by black-pigmented Bacteroides species.

Authors:  J Carlsson; J F Höfling; G K Sundqvist
Journal:  J Med Microbiol       Date:  1984-08       Impact factor: 2.472

7.  Selective removal of albumin from plasma by affinity chromatography.

Authors:  J Travis; R Pannell
Journal:  Clin Chim Acta       Date:  1973-11-23       Impact factor: 3.786

8.  Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.

Authors:  K Sueishi; S Nanno; K Tanaka
Journal:  Thromb Haemost       Date:  1981-02-23       Impact factor: 5.249

9.  Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis.

Authors:  T Nilsson; J Carlsson; G Sundqvist
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

10.  Fibrinogenolytic and fibrinolytic activity in oral microorganisms.

Authors:  M B Wikström; G Dahlén; A Linde
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

View more
  23 in total

1.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

2.  Functional implication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease.

Authors:  Peter L W Yun; Arthur A Decarlo; Cheryl C Chapple; Neil Hunter
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins.

Authors:  Karolina Plaza; Magdalena Kalinska; Oliwia Bochenska; Ulf Meyer-Hoffert; Zhihong Wu; Jan Fischer; Katherine Falkowski; Laura Sasiadek; Ewa Bielecka; Barbara Potempa; Andrzej Kozik; Jan Potempa; Tomasz Kantyka
Journal:  J Biol Chem       Date:  2016-06-27       Impact factor: 5.157

4.  Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.

Authors:  T Imamura; K Matsushita; J Travis; J Potempa
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83.

Authors:  J P Lewis; J A Dawson; J C Hannis; D Muddiman; F L Macrina
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

6.  Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV.

Authors:  A Banbula; M Bugno; J Goldstein; J Yen; D Nelson; J Travis; J Potempa
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue.

Authors:  T Into; M Inomata; Y Kanno; T Matsuyama; M Machigashira; Y Izumi; T Imamura; M Nakashima; T Noguchi; K Matsushita
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

8.  Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.

Authors:  Małgorzata Benedyk; Piotr Mateusz Mydel; Nicolas Delaleu; Karolina Płaza; Katarzyna Gawron; Aleksandra Milewska; Katarzyna Maresz; Joanna Koziel; Krzysztof Pyrc; Jan Potempa
Journal:  J Innate Immun       Date:  2015-11-28       Impact factor: 7.349

9.  The chymotrypsin-like protease complex of Treponema denticola ATCC 35405 mediates fibrinogen adherence and degradation.

Authors:  Caroline V Bamford; J Christopher Fenno; Howard F Jenkinson; David Dymock
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

10.  Impaired plasma clottability induction through fibrinogen degradation by ASP, a serine protease released from Aeromonas sobria.

Authors:  Takahisa Imamura; Hidetoshi Nitta; Yoshihiro Wada; Hidetomo Kobayashi; Keinosuke Okamoto
Journal:  FEMS Microbiol Lett       Date:  2008-05-06       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.